Skip to content

Main Navigation

Clinical Study

ReNu: Neurofibromatosis Type 1 (NF1) Plexiform Neurofibromas trial

The purpose of this study is to determine the effectiveness of the study drug at improving a plexiform neurofibroma (PN) that is causing significant issues in people with neurofibromatosis Type 1 (NF1). This study is for people 2 years of age and older


For more information contact:

Jenny Billy

IRB#: IRB_00124623 | PI: David Viskochil | Department: PEDIATRIC GENETICS | Approval Date: 2020-05-27 06:00:00
Specialties: Pediatric Genetics

Who can participate?

 Gender: All

 Age: All Ages

 Volunteers: Volunteers with special conditions

 Location: In Person

Will I be paid for my time?


Last Updated: 4/5/21